lysergic acid diethylamide has been researched along with clonazepam in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Kodesh, A; Lerner, AG; Shufman, E; Sigal, M; Skladman, I | 1 |
Finkel, B; Gelkopf, M; Lerner, AG; Oyffe, I; Sigal, M; Skladman, I; Weizman, A | 1 |
Bleich, A; Gelkopf, M; Lerner, AG; Nachshon, H; Rudinski, D; Skladman, I | 1 |
2 review(s) available for lysergic acid diethylamide and clonazepam
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.
Topics: Clonazepam; Clonidine; Dopamine Antagonists; GABA Modulators; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Sympatholytics | 2002 |
1 trial(s) available for lysergic acid diethylamide and clonazepam
Article | Year |
---|---|
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.
Topics: Adolescent; Adult; Anxiety; Clonazepam; Drug Administration Schedule; Female; GABA Modulators; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Perceptual Disorders; Recurrence; Substance-Related Disorders; Treatment Outcome | 2003 |
1 other study(ies) available for lysergic acid diethylamide and clonazepam
Article | Year |
---|---|
LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.
Topics: Adult; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Lysergic Acid Diethylamide; Male; Perceptual Disorders; Substance Withdrawal Syndrome | 2001 |